Earnings call transcript: Elite Pharmaceuticals Q2 2027 revenue rises 10% as stock jumps
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.